Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Befact is a brand of oral vitamin B complex supplements developed and manufactured by Laboratoires SMB in Belgium. The product line includes several formulations, most notably Befact Forte, which combines thiamine mononitrate (B1), riboflavin (B2), pyridoxine hydrochloride (B6), and cyanocobalamin (B12). These products are indicated for the prevention and treatment of vitamin B deficiencies, particularly in high-risk populations such as those with chronic alcoholism, severe malnutrition, or individuals following restrictive diets. Clinically, Befact is used to manage conditions like alcoholic polyneuropathy and polyneuritis. The vitamins in the formulation act as essential cofactors for a wide range of metabolic enzymes involved in energy production, neurological health, and cellular maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Befact.